Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to GT200100093ApriorityCriticalpatent/GT200100093A/en
Publication of GT200100093ApublicationCriticalpatent/GT200100093A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
EL INVENTO DESCRIBE UNA COMPUESTOS DERIVADOS DE PIRAZOL PASA SU USO EN EL TRATAMIENTO DE DESORDENES MEDIADOS POR CINASA P38. ESPECIFICAMENTE EN EL TRATAMIENTO DE PROBLEMAS INFLAMATORIOS CAUSDOS PRO TUMORES, VIRUS QUE AFECTAN A LOS SERES HUMANAS COMO EL HERPES Y EL VIH.THE INVENTION DESCRIBES A COMPOUNDS DERIVED FROM PIRAZOL PASSES ITS USE IN THE TREATMENT OF DISORDERS MEDIAATED BY CINASA P38. SPECIFICALLY IN THE TREATMENT OF INFLAMMATORY PROBLEMS CAUSED PRO TUMORS, VIRUSES AFFECTING HUMAN BEINGS LIKE HERPES AND HIV.
GT200100093A2001-05-232001-05-23
PIRAZOLES REPLACED AS INHIBITORS OF CINASA P38
GT200100093A
(en)
COMPOUNDS DERIVED FROM PIRAZOL, ITS ADDITION SALTS ACIDS, HIV DISORDERS AND GENETICALLY RELATED VIRUSES. HYDRATES, SOLVATES; PHARMACEUTICAL COMPOSITIONS; AND ITS USE IN THE TREATMENT OF GENETICALLY RELATED HIV DISORDERS AND VIRUSES.